US Stocks
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc. (VRTX)


  • $







Key Stats

Today Low/High$228.32 / $234.39
52 Week Low/High$176.36 / $242.99
P/E ratio27.44
Market Cap$58.69B

Company Details

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) - a rare, life-threatening genetic disease - and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, Vertex has a rapidly expanding pipeline of cell and genetic therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.
OrganisationVertex Pharmaceuticals, Inc.
HeadquatersBoston, Massachusetts, US
IndustryHealth Technology
Company Financials
  • Annual P&L
  • Quarterly P&L

Discover more

Frequently Asked Questions

What is Vertex Pharmaceuticals, Inc. (VRTX) share price today?

Can Indians buy Vertex Pharmaceuticals, Inc. (VRTX) shares?

How can I buy Vertex Pharmaceuticals, Inc. (VRTX) shares from India?

Can Fractional shares of Vertex Pharmaceuticals, Inc. (VRTX) be purchased?

What are the documents required to start investing in Vertex Pharmaceuticals, Inc. (VRTX) stocks?